Beyond the Cholesterol Profile: Monitoring Therapeutic Effectiveness of Statin Therapy

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2001 Aug 2

PMID 11481576

Citations 2

Authors

R G Schwartz

Affiliations

Soon will be listed here.

Citing Articles

Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.

Schwartz R J Nucl Cardiol. 2010; 17(6):985-9.

PMID: 20963538 DOI: 10.1007/s12350-010-9295-2.

Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.

Shaw L, Heller G, Casperson P, Miranda-Peats R, Slomka P, Friedman J J Nucl Cardiol. 2006; 13(5):685-98.

PMID: 16945749 DOI: 10.1016/j.nuclcard.2006.06.134.

References

Shepherd J, Cobbe S, Ford I, Isles C, LORIMER A, Macfarlane P . Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995; 333(20):1301-7. DOI: 10.1056/NEJM199511163332001. View

Shaw L, Hachamovitch R, Berman D, Marwick T, Lauer M, Heller G . The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter.... J Am Coll Cardiol. 1999; 33(3):661-9. DOI: 10.1016/s0735-1097(98)00606-8. View

Beaumont V, JACOTOT B, Beaumont J . Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis. 1976; 24(3):441-50. DOI: 10.1016/0021-9150(76)90136-2. View

Goldstein J, Dana S, Brunschede G, Brown M . Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor. Proc Natl Acad Sci U S A. 1975; 72(3):1092-6. PMC: 432472. DOI: 10.1073/pnas.72.3.1092. View

Perez-Sala D, Hernandez G, Diaz C, Lamas S . Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest. 1998; 101(12):2711-9. PMC: 508862. DOI: 10.1172/JCI1500. View

Downs J, Clearfield M, Weis S, Whitney E, Shapiro D, Beere P . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998; 279(20):1615-22. DOI: 10.1001/jama.279.20.1615. View

Guethlin M, Kasel A, Coppenrath K, Ziegler S, Delius W, Schwaiger M . Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation. 1999; 99(4):475-81. DOI: 10.1161/01.cir.99.4.475. View

Sacks F, Pfeffer M, Moye L, Rouleau J, Rutherford J, Cole T . The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996; 335(14):1001-9. DOI: 10.1056/NEJM199610033351401. View

Yokoyama I, Momomura S, Ohtake T, Yonekura K, Yang W, Kobayakawa N . Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy. Circulation. 1999; 100(2):117-22. DOI: 10.1161/01.cir.100.2.117. View

10.

Brown K . Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation. 1991; 83(2):363-81. DOI: 10.1161/01.cir.83.2.363. View

11.

Hachamovitch R, Berman D, Shaw L, Kiat H, Cohen I, Cabico J . Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998; 97(6):535-43. DOI: 10.1161/01.cir.97.6.535. View

12.

Gibson R, WATSON D, CRADDOCK G, Crampton R, Kaiser D, DENNY M . Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation. 1983; 68(2):321-36. DOI: 10.1161/01.cir.68.2.321. View

13.

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998; 280(7):605-13. DOI: 10.1001/jama.280.7.605. View

14.

Lerman A, Holmes Jr D, Bell M, Garratt K, Nishimura R, Burnett Jr J . Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995; 92(9):2426-31. DOI: 10.1161/01.cir.92.9.2426. View

15.

Cushman M, Legault C, Barrett-Connor E, Stefanick M, Kessler C, Judd H . Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 1999; 100(7):717-22. DOI: 10.1161/01.cir.100.7.717. View

16.

Gould K, Ornish D, Scherwitz L, Brown S, Edens R, Hess M . Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995; 274(11):894-901. DOI: 10.1001/jama.1995.03530110056036. View

17.

Kang X, Berman D, Lewin H, Cohen I, Friedman J, Germano G . Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J. 1999; 138(6 Pt 1):1025-32. DOI: 10.1016/s0002-8703(99)70066-9. View

18.

Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M . Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 1996; 94(12):3232-8. DOI: 10.1161/01.cir.94.12.3232. View

19.

. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998; 339(19):1349-57. DOI: 10.1056/NEJM199811053391902. View

20.

Zeiher A, Drexler H, Wollschlager H, Just H . Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991; 84(5):1984-92. DOI: 10.1161/01.cir.84.5.1984. View